abstract |
Patients with elevated blood levels of low-density lipoprotein (LDL) and total cholesterol are treated by administering beta -hydroxy- beta -methylbutyric acid (HMB) to reduce the patient's blood level of LDL and total cholesterol. HMB can be safely administered orally to humans in amounts that will significantly reduce blood levels of total cholesterol and LDL. |